Branding, Gene Silencing and RNA - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Branding

Gene Silencing

RNA

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

JUNE 14, 2023

The exact cost of Vevye has not been publicly disclosed; however, it is estimated that the price of Vevye may be in the range of similar cyclosporine ophthalmic emulsions, such as brand-name Restasis that carries a list price of $645.63 for a 30-day supply (without insurance coverage).

Gene Silencing

Gene Silencing Drug Delivery FDA Approval RNA

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Pharma Marketing Network

DECEMBER 21, 2020

those that modify the expression of an individual’s genes or repair abnormal genes) has entered clinical practice, including 11 RNA therapeutics, 2 in vivo gene therapies, and 2 gene-modified cell therapies. Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e.,

Genetics

Genetics Medicine Gene Therapy Marketing

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Vevye: A New Cyclosporine Solution for Dry Eye Disease

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Webinars

Stay Connected